Business News • MarketWire • AVI BioPharma Prices $30.0 Million Public Offering of Common Stock |
AVI BioPharma Prices $30.0 Million Public Offering of Common Stock |
|
|
AVI BioPharma Prices $30.0 Million Public Offering of Common Stock
BOTHELL, WA--(Marketwire - April 1, 2011) - AVI BioPharma, Inc. (NASDAQ: AVII) today announced that it has priced an underwritten public offering of 20,000,000 shares of its common stock at a price to the public of $1.50 per share for gross proceeds of $30.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by the Company, will be approximately $27.8 million. The Company has also granted the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any, which would result in additional gross proceeds of $4.5 million if exercised in full.
View More : http://www.marketwire.com/mw/release.do?id=1421207&sourceType=3
|
|
|